Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Operations (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Cash from Operations for 16 consecutive years, with 23157000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 52.53% to 23157000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 81251000.0, a 84.14% increase, with the full-year FY2025 number at 81251000.0, up 84.14% from a year prior.
  • Cash from Operations was 23157000.0 for Q4 2025 at Lemaitre Vascular, down from 28764000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 28764000.0 in Q3 2025 to a low of 2279000.0 in Q1 2023.
  • A 5-year average of 11130300.0 and a median of 9761000.0 in 2021 define the central range for Cash from Operations.
  • Biggest YoY gain for Cash from Operations was 410.85% in 2021; the steepest drop was 64.27% in 2021.
  • Lemaitre Vascular's Cash from Operations stood at 5056000.0 in 2021, then decreased by 19.36% to 4077000.0 in 2022, then surged by 163.58% to 10746000.0 in 2023, then surged by 41.28% to 15182000.0 in 2024, then surged by 52.53% to 23157000.0 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Cash from Operations are 23157000.0 (Q4 2025), 28764000.0 (Q3 2025), and 20291000.0 (Q2 2025).